Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Benny_Sorensen
|
| gptkbp:developedBy |
monoclonal antibody therapeutics
|
| gptkbp:focusesOn |
rare bleeding disorders
|
| gptkbp:foundedIn |
2019
|
| gptkbp:fundedBy |
gptkb:Series_B
|
| gptkbp:headquartersLocation |
gptkb:Copenhagen,_Denmark
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hemab Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:HealthCap
gptkb:OrbiMed gptkb:RA_Capital_Management gptkb:V-Bio_Ventures gptkb:Rock_Springs_Capital gptkb:Novo_Holdings |
| gptkbp:leadProgramIndication |
gptkb:Glanzmann_thrombasthenia
|
| gptkbp:program |
gptkb:HEM-101
|
| gptkbp:website |
https://www.hemab.com/
|
| gptkbp:bfsParent |
gptkb:John_Maraganore
|
| gptkbp:bfsLayer |
6
|